13 LIFE SCIENCE FUNDS
Abingworth has raised 13 funds dedicated to investing in life sciences and healthcare. Our most recent, Abingworth Bioventures 8 and Abingworth Clinical Co-Development Fund, raised $465 million and $108 million respectively and are actively investing.
Venture Funds
Our venture funds invest across our broad strategic areas of venture capital, clinical co-development, VIPEs and public markets. They focus primarily on private companies but invest a percentage of their value in public companies.